Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Barakaldo
Clinical trial register · Spain

Clinical Trials in Barakaldo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5909 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
5909
Studies in scope
all four open statuses
3100
Recruiting now
open to new participants
1129
Lead sponsors
across recruiting studies
Top sites
Barcelona 3245 Madrid 3071 Valencia 1206 Seville 1059 Málaga 762

Trials with a site in Barakaldo

140 of 5909 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant Recipients
NCT07898774C3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Recurrent Glomerular Disease After Kidney Transplantation
Swedish Orphan Biovitrum
Phase 3
30
Barcelona, A Coruña, Madrid, Málaga, Barakaldo
2027-01-21
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
NCT07871864Osteosarcoma, Pediatric Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
530
Barakaldo, Barcelona, Madrid, Murcia, Santa Cruz de Tenerife, Seville, Valencia, Zaragoza
2026-10-07
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
AstraZeneca
Phase 3
600
A Coruña, Barakaldo, Barcelona, Granollers, Madrid
2026-09-24
Recruiting
MedSIR
Phase 1/2
278
Badalona, Barakaldo, Barcelona, Madrid, Málaga, San Cristóbal de La Laguna, Seville, Zaragoza
2026-08-20
Recruiting
Boehringer Ingelheim
Phase 3
448
Badalona, Barakaldo, Barcelona, Huelva, L'Hospitalet Del Llobregat, Madrid, Sabadell, Valencia
2026-07-27
Active, closed
Jesus Villar
Observational
1,241
Barakaldo, Albacete, Barcelona, León, Madrid, Murcia, Valencia, Valladolid
2026-07-13
Recruiting
PETHEMA Foundation
Phase 3
376
Santiago de Compostela, Hospitalet Del Llobregat, Terrassa, Jaén, Alcalá de Henares, San Sebastián de los Reyes, Málaga, Barakaldo
2026-07-02
Active, closed
Basque Health Service
Not applicable
4,680
Barakaldo
2026-07-01
Recruiting
Prilenia
Phase 3
400
Barakaldo, Barcelona, Madrid, Oviedo, Seville
2026-07-01
Not yet open
Hospital Universitari Vall d'Hebron Research Institute
Phase 3
15,160
Granada, Barcelona, Girona, Tarragona, Barakaldo, A Coruña, Alicante, Burgos
2026-07-01
Not yet open
Reduction of Low-value Prescribing Through Audit and Feedback
NCT07336550Inappropriate Prescribing, Implementation Science, Behavioral Sciences
Basque Health Service
Not applicable
540
Barakaldo
2026-06
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
L'Hospitalet de Llobregat, Barakaldo, Barcelona, Málaga, Badajoz, Madrid, Seville, Valencia
2026-05-04
Recruiting
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
NCT07585890End-stage Liver Disease (ESLD), Acute Liver Failure, Liver Cirrhosis, Liver Transplantation
University Medical Center Groningen
Observational
10,000
Barakaldo, Barcelona, Granada, Madrid, Seville, Valladolid
2026-04-21
Recruiting
Bristol-Myers Squibb
Phase 3
850
L'Hospitalet Del Llobregat, Barcelona, Madrid, Valencia, Barakaldo, Málaga, Seville, Zaragoza
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
750
Barcelona, Barakaldo, Jaén, Madrid, Málaga, Murcia
2026-03-12
Recruiting
Hoffmann-La Roche
Phase 2
100
Barakaldo, Córdoba, Madrid, Valencia
2026-03-11
Recruiting
Hoffmann-La Roche
Phase 2
360
L'Hospitalet de Llobregat, Salt, Santiago de Compostela, Lleida, Pozuelo de Alarcón, El Palmar, Vigo, Barakaldo
2026-03-10
Recruiting
Instituto de Investigación Biomédica de Salamanca
Phase 3
300
Salamanca, Almería, Barakaldo, Girona, Las Palmas de Gran Canaria, Madrid, Murcia, Santander
2026-03-01
Recruiting
Biobizkaia Health Research Institute
Phase 3
86
Barakaldo, Bilbao
2026-02-24
Recruiting
Boehringer Ingelheim
Phase 3
1,325
A Coruña, Alicante, Barakaldo, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Salamanca
2026-02-17
Recruiting
Eli Lilly and Company
Phase 3
300
Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Santander, Seville, Valencia
2026-02-05
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
390
A Coruña, Alicante, Barakaldo, Barcelona, Granada, Jerez de la Frontera, Madrid, Santa Cruz de Tenerife
2026-01-12
Recruiting
Eli Lilly and Company
Phase 3
150
Barakaldo, Esplugues de Llobregat, Madrid
2026-01-12
Recruiting
Grupo Español de Investigación en Neurooncología
Phase 2
56
Palma de Mallorca, Barcelona, Barakaldo, Granada, Madrid, Vigo, Salamanca, Seville
2025-12-19
Recruiting
Fundación EPIC
Not applicable
2,100
Alicante, Badalona, Barakaldo, Barcelona, Castelló, Donostia / San Sebastian, El Palmar, Fuencarral-El Pardo
2025-12-19
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
450
Badajoz, Badalona, Barakaldo, Barcelona, Córdoba, Elche, Girona, Hospitalet
2025-12-12
Recruiting
SAb Biotherapeutics, Inc.
Phase 2
159
Barakaldo, Seville
2025-11-25
Recruiting
Takeda
Observational
10
L'Hospitalet de Llobregat, Barakaldo, Barcelona, Córdoba, Madrid, Málaga, Seville
2025-11-03
Active, closed
Femasys Inc.
Observational
200
Logroño, Badajoz, Barakaldo, Bilbao, Burgos, Córdoba, Granada, Las Palmas de Gran Canaria
2025-10-22
Recruiting
TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)
NCT07284277Pancreatic Adenocarcinoma Metastatic, Pancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra
Phase 1/2
30
Pamplona, Barakaldo, Galdakao, Madrid, Vitoria-Gasteiz
2025-10-14
Active, closed
AstraZeneca
Phase 3
71
A Coruña, Badajoz, Barakaldo, Barcelona, Madrid, Málaga, Oviedo, Santander
2025-09-15
Recruiting
Basilea Pharmaceutica
Phase 3
234
Seville, Barcelona, Barakaldo, Madrid
2025-08-26
Recruiting
Takeda
Phase 3
347
Badalona, Barakaldo, Pamplona, Barcelona, Madrid, Seville
2025-07-15
Recruiting
MedSIR
Phase 2
20
Elche, Barcelona, Girona, Madrid, Reus, Alicante, Barakaldo, León
2025-06-27
Recruiting
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
NCT05815927Oligometastatic Squamous Cell Carcinoma of the Head and Neck
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
200
Badalona, Barakaldo, Barcelona, Las Palmas de Gran Canaria, Madrid, Málaga
2025-05-23
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
450
Badajoz, Barakaldo, Barcelona, Cadiz, Córdoba, Granada, Madrid, Málaga
2025-05-19
Recruiting
Optimising TREATment for Severe Gram-Negative Bacterial Infections
NCT07004049Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, Hospital Acquired Bacterial Pneumonia, Carbapenem Resistant Bacterial Infection
National University of Singapore
Phase 4
600
Alicante, Badajoz, Barakaldo, Barcelona, Córdoba, Granada, Madrid, Málaga
2025-04-21
Active, closed
Janssen Research & Development, LLC
Phase 3
752
Alicante, Barakaldo, Barcelona, Granada, Madrid, Manises, Santiago Compostela, Seville
2025-04-15
Recruiting
AstraZeneca
Phase 3
990
Barakaldo, Barcelona, Granada, Madrid, Málaga, Palma de Mallorca, Pamplona, Seville
2025-03-18
Recruiting
Fundación EPIC
Not applicable
200
Barakaldo, Oviedo, Valladolid
2025-03-14
Active, closed
Celgene
Phase 3
960
Córdoba, Barcelona, Sabadell, Barakaldo, Santander, Lugo, Madrid, Majadahonda
2025-03-13
Recruiting
Summit Therapeutics
Phase 3
780
Barakaldo, Santander, Badajoz, Las Palmas, Madrid, Sevilla, Marbella, Seville
2025-02-27
Not yet open
University Hospital Schleswig-Holstein
Not applicable
27
Barakaldo
2025-02-15
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,000
Albacete, Alicante, Barakaldo, Burgos, Cadiz, Cantabria, Córdoba, Donostia / San Sebastian
2025-02-12
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Seville, L'Hospitalet de Llobregat, Barakaldo, Las Palmas de Gran Canaria, Majadahonda, Gijón, Alicante, Barcelona
2025-01-27
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
NCT06680830Parkinson Disease, Parkinson, Idiopathic Parkinson Disease, Early Parkinson Disease (Early PD)
Neuron23 Inc.
Phase 2
150
San Sebastián, Barakaldo, Barcelona, Madrid, Móstoles, Seville
2025-01-17
Recruiting
Novo Nordisk A/S
Phase 3
480
Barakaldo, Barcelona, Madrid
2025-01-10
Recruiting
Instituto de Investigación Marqués de Valdecilla
Phase 4
75
Barakaldo, Jerez de la Frontera, Madrid, Salamanca, Santander, Seville, Valladolid
2024-12-31
Active, closed
AstraZeneca
Phase 3
45
A Coruña, Alicante, Barakaldo, Barcelona, Córdoba, El Palmar, Girona, L'Hospitalet de Llobregat
2024-12-30
Recruiting
Basilea Pharmaceutica
Phase 3
450
Seville, Barcelona, Madrid, Barakaldo
2024-12-11
Recruiting
OSE Immunotherapeutics
Phase 3
363
Palma de Mallorca, Badalona, Barcelona, L'Hospitalet de Llobregat, Barakaldo, Córdoba, Girona, A Coruña
2024-12-03
Recruiting
Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
NCT06180356Ovarian Cancer, Oligometastatic Disease, Serous Ovarian Tumor
MedSIR
Phase 2
30
A Coruña, Barakaldo, Barcelona, Girona, Jaén, Madrid, Málaga, Oviedo
2024-12-03
Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
NCT06369285Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer
Puma Biotechnology, Inc.
Phase 2
225
Alicante, Barakaldo, Barcelona, Bilbao, Cáceres, Granada, Huelva, Jaén
2024-11-19
Recruiting
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 4
284
Alava, Barakaldo, Barcelona, Donostia / San Sebastian, Granada, Logroño, Madrid, Málaga
2024-10-09
Recruiting
Efficacy of INM004 in Children With STEC-HUS
NCT06389474Hemolytic-Uremic Syndrome
Inmunova S.A.
Phase 3
220
Barakaldo, Madrid
2024-10-05
Active, closed
AstraZeneca
Phase 3
768
A Coruña, Barakaldo, Barcelona, El Palmar, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga
2024-10-04
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
349
Barakaldo, Barcelona, Elche, Madrid, Pamplona, Seville, Valencia
2024-10-02
Active, closed
Cerevance
Phase 3
330
Seville, Sant Cugat del Vallès, Barakaldo, San Sebastián, Valencia, Barcelona, Madrid
2024-09-20
Active, closed
POWER AUDIT, Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol After Gastric Surgery (POWER 4 + 3)
NCT06790238Adenocarcinoma of Stomach, Critical Pathways, Enhanced Recovery After Surgery (ERAS) Protocol, Retrospective Studies
Grupo Español de Rehabilitación Multimodal
Observational
350
Alcázar de San Juan, Barakaldo, Barcelona, Bilbao, Ciudad Real, Fuenlabrada, Guadalajara, Inca
2024-09-01
Active, closed
Ferrer Internacional S.A.
Phase 2
241
A Coruña, Badalona, Barakaldo, Barcelona, Madrid, Pamplona, Seville, Valencia
2024-07-23
Recruiting
Fundacion Oncosur
Phase 2
78
Badalona, Barcelona, Sabadell, Santander, Cadiz, Madrid, Málaga, Barakaldo
2024-07-05
Not yet open
Biobizkaia Health Research Institute
Observational
6,160
Barakaldo, Seville
2024-07
Active, closed
Celgene
Phase 3
850
A Coruña, Badalona, L'Hospitalet Del Llobregat, Barakaldo, Santa Cruz de Tenerife, Donostia / San Sebastian, Majadahonda, El Palmar, Murcia
2024-06-19
Recruiting
Trak Health Solutions S.L.
Not applicable
20
Barakaldo
2024-06-05
Recruiting
Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)
NCT07240038Pneumonia Ventilator Associated, Pneumonia Neonatal, Healthcare-associated Infections
Biobizkaia Health Research Institute
Observational
1,500
A Coruña, Santiago de Compostela, Albacete, Badalona, Barcelona, Barakaldo, Bilbao, Burgos
2024-04-26
Active, closed
Amgen
Phase 3
111
Barakaldo, Barcelona, Esplugues de Llobregat, Getafe, Valencia, Madrid
2024-04-22
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
Sanofi
Phase 3
2,500
A Coruña, Seville, Barcelona, L'Hospitalet de Llobregat, Barakaldo, Santiago de Compostela, Donostia / San Sebastian, Salt
2024-04-16
Active, closed
Fundación EPIC
Observational
501
Albacete, Alicante, Barakaldo, Boadilla del Monte, Ciudad Real, Granada, Huelva, L'Hospitalet de Llobregat
2024-02-26
Active, closed
AstraZeneca
Phase 2
142
Barakaldo, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Valencia, Zaragoza
2024-02-22
Recruiting
AstraZeneca
Phase 3
5,250
Alicante, Badia Del Vallès, Barakaldo, Barcelona, Castro Urdiales, Córdoba, Granada, Madrid
2024-02-21
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Alicante, Barakaldo, Barcelona, Granada, L'Hospitalet de Llobregat, Madrid, Valencia
2024-01-17
Active, closed
Sanofi
Phase 3
943
Murcia, Barcelona, Barakaldo, L'Hospitalet de Llobregat, Donostia / San Sebastian, Girona, Las Palmas de Gran Canaria, Lleida
2023-12-27
Recruiting
Eli Lilly and Company
Phase 3
1,264
A Coruña, Badajoz, Barakaldo, Barcelona, Hospitalet, Jerez de la Frontera, Las Palmas de Gran Canaria, León
2023-12-21
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Alicante, Barakaldo, El Palmar, Girona, Granada, L'Hospitalet de Llobregat, Lleida, Madrid
2023-12-15
Active, closed
Sanofi
Phase 3
1,655
Murcia, Barcelona, Barakaldo, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Pontevedra, Seville, Córdoba
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Santiago de Compostela, Málaga, Seville, Palma, Barakaldo, Santander, A Coruña, Pozuelo de Alarcón
2023-12-12
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Seville, Sabadell, Terrassa, Barakaldo, Majadahonda, Pozuelo de Alarcón, Pamplona, Oviedo
2023-11-14
Active, closed
AstraZeneca
Phase 3
863
Barakaldo, Barcelona, Madrid, Oviedo
2023-11-09
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Albacete, Alicante, Alzira, Barakaldo, Barcelona, Bilbao, Cadiz, Cáceres
2023-10-24
Active, closed
AstraZeneca
Phase 3
5,511
A Coruña, Albacete, Alicante, Badalona, Barakaldo, Barcelona, Burgos, Castellon
2023-10-05
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Badalona, L'Hospitalet de Llobregat, Barakaldo, Santander, Majadahonda, Badajoz, Barcelona, L'Hospitaler de Llobregat
2023-09-22
Active, closed
Novartis Pharmaceuticals
Phase 2
144
Barakaldo, Barcelona, Burgos, Madrid
2023-08-25
Recruiting
Coroflex® ISAR NEO PMCF Study
NCT05698732Coronary Artery Disease (CAD), Ischemic Heart Disease
Fundación EPIC
Observational
3,000
A Coruña, Badajoz, Badalona, Barakaldo, Barcelona, Cáceres, Ciudad Real, Huelva
2023-08-04
Active, closed
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy
Theravance Biopharma
Phase 3
102
Terrassa, Barakaldo, Madrid
2023-06-27
Active, closed
Swedish Orphan Biovitrum
Observational
165
Badalona, Barakaldo, Barcelona, Bilbao, Donostia / San Sebastian, El Palmar, Huelva, Las Palmas de Gran Canaria
2023-06-26
Recruiting
ModernaTX, Inc.
Observational
60
Esplugues de Llobregat, Santander, Barakaldo, Madrid, Seville, Valencia
2023-06-16
Recruiting
SUPRAFLEX CRUZ PMCF Study ( rEpic05 )
NCT05617599Coronary Artery Disease (CAD), Ischemic Heart Disease
Fundación EPIC
Observational
508
Elche, A Coruña, Barakaldo, Barcelona, Castelló, Cáceres, Ciudad Real, Girona
2023-05-10
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Barakaldo, Madrid
2023-05-09
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc.
Phase 3
880
Barakaldo, Barcelona, Madrid, Málaga, Valencia, Valladolid
2023-04-25
Recruiting
AstraZeneca
Phase 3
4,300
A Coruña, Albacete, Alcoy, Alicante, Alzira, Badajoz, Badalona, Barakaldo
2023-03-31
Active, closed
Sequent Extended Study
NCT05788432Coronary Artery Disease, Ischemic Heart Disease
Fundación EPIC
Observational
2,040
Alava, Alicante, Badajoz, Badalona, Barakaldo, Barcelona, Cadiz, Castelló
2023-03-28
Recruiting
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
NCT05781217Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence, Androgen Deprivation Therapy
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Phase 3
534
L'Hospitalet de Llobregat, Fuenlabrada, Pozuelo de Alarcón, Barakaldo, Barcelona, Madrid, Tarragona, Valencia
2023-03-14
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
Day One Biopharmaceuticals, Inc.
Phase 3
418
Barakaldo, Barcelona, Madrid, Seville, Valencia
2023-02-27
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
A Coruña, Albacete, Alicante, Badalona, Barakaldo, Barcelona, Córdoba, Girona
2023-02-15
Active, closed
Hoffmann-La Roche
Phase 2
301
Barakaldo, Badajoz, Barcelona, Burgos, Madrid, Seville, Valencia
2023-02-03
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
297
Barakaldo, Barcelona, Jerez de la Frontera, Madrid, Murcia, Sabadell, Seville, Valencia
2022-11-23
Recruiting
Fundacion Clinic per a la Recerca Biomédica
Phase 4
360
Alicante, Seville, Palma de Mallorca, Barcelona, Sabadell, Terrassa, Barakaldo, Santander
2022-08-17
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
Panbela Therapeutics, Inc.
Phase 2/3
600
Badalona, Santander, Jaén, Barcelona, Madrid, El Palmar, Pamplona, Barakaldo
2022-08-08
Recruiting
Neck Evolution With Ovation in Spain
NCT05823519Abdominal Aortic Aneurysm
DGM Vascular
Observational
120
Palma de Mallorca, Girona, Barakaldo, Burgos, Salamanca, Toledo, Gijón, Barcelona
2022-06-01
Active, closed
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 4
306
Palma de Mallorca, L'Hospitalet de Llobregat, Sabadell, Barakaldo, Jerez de la Frontera, Puerto Real, Donostia / San Sebastian, Logroño
2022-04-28
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
A Coruña, Barakaldo, Barcelona, Bilbao, Córdoba, Ferrol, Madrid, Santander
2022-03-15
Active, closed
Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients
NCT05193019Ischemic Heart Disease, Acute Coronary Syndrome
Fundación EPIC
Observational
717
L'Hospitalet de Llobregat, Barakaldo, Galdakao, Gijón, León, Madrid, Pamplona, Salamanca
2022-03-14
Active, closed
Boston Scientific Corporation
Not applicable
500
Barakaldo, Madrid
2021-12-21
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Barakaldo, Barcelona, Jerez de la Frontera, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Lugo, Madrid, Málaga
2021-12-10
Active, closed
Sanofi
Phase 2
22
Barakaldo, Barcelona, Madrid, Seville
2021-12-07
Active, closed
Gilead Sciences
Phase 3
603
A Coruña, Badalona, Barakaldo, Barcelona, Cáceres, Girona, Madrid, Málaga
2021-11-17
Recruiting
ModernaTX, Inc.
Phase 1/2
50
Barakaldo, Madrid
2021-11-09
Active, closed
Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice
NCT04899141Coronary Artery Disease, Ischemic Heart Disease
Fundación EPIC
Observational
400
Málaga, Barakaldo, Barcelona, Cáceres, Ciudad Real, Donostia / San Sebastian, Elche, Galdakao
2021-10-29
Active, closed
Novartis Pharmaceuticals
Phase 3
129
Barakaldo, Seville
2021-10-05
Active, closed
Janssen Research & Development, LLC
Phase 4
411
A Coruña, Barakaldo, Barcelona, Bilbao, Córdoba, Madrid, Málaga, Sabadell
2021-08-30
Active, closed
ANGiographic Evaluation of Left Main Coronary Artery INtErvention
NCT04604197Coronary Occlusion, Left Main Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease
Fundación EPIC
Not applicable
400
Badalona, Barakaldo, Donostia / San Sebastian, Málaga, Galdakao, A Coruña, Albacete, Alicante
2021-04-16
Recruiting
ModernaTX, Inc.
Phase 1/2
77
Esplugues de Llobregat, Barakaldo, Madrid, Seville
2021-04-15
Active, closed
Takeda
Phase 3
77
A Coruña, Barakaldo
2021-04-14
Recruiting
Bristol-Myers Squibb
Phase 3
153
Alicante, Barakaldo, Esplugues de Llobregat, Las Palmas de GC, Madrid
2021-03-23
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Pamplona, A Coruña, Alicante, Badalona, Barakaldo, Barcelona, Córdoba, Girona
2021-02-23
Active, closed
Forma Therapeutics, Inc.
Phase 3
450
A Coruña, Badalona, Barakaldo, Barcelona, Madrid, Seville
2021-01-29
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Albacete, Alcorcón, Alcoy, Alicante, Almería, Asturias, Badajoz, Barakaldo
2021-01-15
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565HER2-negative Breast Cancer, Triple Negative Breast Cancer
GBG Forschungs GmbH
Phase 3
1,332
Barakaldo, A Coruña, Albacete, Alcorcón, Alcoy, Alicante, Badalona, Barcelona
2020-10-28
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome
University of Siena
Observational
3,500
Barakaldo, Barcelona, Madrid, Santander, Valencia
2020-08-06
Recruiting
Mats Heyman
Phase 3
6,430
Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Palma de Mallorca, Seville, Valencia, Zaragoza
2020-07-13
Active, closed
Balt Extrusion
Observational
234
Barakaldo, Madrid, Oviedo, Valladolid
2019-11-04
Recruiting
Mats Heyman
Observational
500
Alicante, Barakaldo, Barcelona, Fuencarral-El Pardo, Madrid, Murcia, Palma de Mallorca, Santander
2019-08-29
Recruiting
University Hospital Muenster
Phase 3
683
Alicante, Almería, Badajoz, Barakaldo, Barcelona, Donostia / San Sebastian, Esplugues de Llobregat, Granada
2019-08-23
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene
Phase 3
665
Barakaldo, Barcelona, Madrid, Oviedo, Salamanca, Seville, Valencia
2019-08-12
Active, closed
Sanofi
Observational
955
Bilbao, Las Palmas de Gran Canaria, Majadahonda, Oviedo, Barakaldo, Barcelona, Madrid, Santiago de Compostela
2019-06-11
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Barakaldo, Barcelona, Madrid, Málaga, Seville
2018-10-29
Active, closed
Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency
NCT03636438Ornithine Transcarbamylase (OTC) Deficiency
Ultragenyx Pharmaceutical Inc
Observational
11
Santiago de Compostela, Barakaldo
2018-08-30
Active, closed
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
NCT03569241Prostate Cancer, Prostate Cancer Metastatic, Metastatic Cancer, Oligometastatic Cancer
University Hospital, Ghent
Phase 2
196
Barakaldo, Bilbao, Madrid, Navarro, Santiago, Valencia
2018-04-27
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Barakaldo, Barcelona, Cartagena, El Palmar, Esplugues de Llobregat, Las Palmas de Gran Canaria, Madrid, Oviedo
2017-09-12
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Barakaldo, Barcelona, Madrid, Oviedo, San Sebastián, Seville, Valladolid, Vigo
2016-12
Active, closed
Geron Corporation
Phase 2/3
289
Cadiz, Majadahonda, Seville, Valencia, Barakaldo, Badalona, Barcelona, Madrid
2016-01-12
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Barakaldo, Barcelona, Castellon, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Reus
2015-11-19
Recruiting
International Rare Histiocytic Disorders Registry (IRHDR)
NCT02285582Rare Histiocytic Disorders (RHDs), Erdheim-Chester Disease (ECD), Rosai-Dorfman Disease (RDD), Xanthogranuloma Family (XG)
The Hospital for Sick Children
Observational
400
Barakaldo
2014-10
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 2/3
360
Barakaldo
2014-06
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Vigo, Barakaldo, Madrid, Málaga, Seville, Valencia
2013-07-26
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Santiago de Compostela, Barakaldo, Logroño, Burela de Cabo, Málaga, Oviedo, Reus, A Coruña
2013-05-30
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Badajoz, Barakaldo, Barcelona, Burgos, Madrid, Palma de Mallorca, Pamplona, Valencia
2012-07
Rows per page Showing 1–140 of 140
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-spain/city/barakaldo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,909 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 140 of those studies with a site in Barakaldo.

How many clinical trials are recruiting in Barakaldo?

78 of the 140 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 4 have not yet opened recruitment, 57 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Barakaldo), 140 studies
PhaseStudiesRecruitingShare
Phase 3734152.1%
Observational291520.7%
Phase 216911.4%
Not applicable835.7%
Phase 4644.3%
Phase 1/2553.6%
Phase 2/3312.1%

Most active sponsors

Lead sponsors with the most studies (Barakaldo)
Lead sponsorStudiesRecruiting
AstraZeneca104
Fundación EPIC94
Janssen Research & Development, LLC50
Sanofi50
Eli Lilly and Company44
ModernaTX, Inc.44
Biobizkaia Health Research Institute32
Bristol-Myers Squibb33
Celgene31
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company31
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.